Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma

Key Points After CAR T cell therapy, macrophage activation syndrome-like disorder is identified by rising ferritin, elevated LDH, and low fibrinogen Antecedent infections may predict macrophage activation syndrome-like disorder development